Cancer Therapy and Research Center

Site:	Cancer Therapy and Research Center	Go to their website
Address:	7979 Wurzbach Rd.
City:	San Antonio
State:	TX
Zip:	78229
Country:	USA

Phase	Trial	Trial Status	Site Status	Drug	NCT#
3	Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor	Terminated	Closed	Imatinib + Bevacizumab	NCT00324987
1	Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients.	Ongoing, but not recruiting	Closed	AUY922	NCT00526045
1	Oral Hydroxychloroquine Plus Oral Sorafenib to Treat Patients With Refractory or Relapsed Solid Tumors	Ongoing, but not recruiting	Closed	Hydroxychloroquine + Sorafenib	NCT01634893
1	Study of Oral CNF2024 in Advanced Solid Tumors	Completed	Closed	BIIB021 (CNF2024)	NCT00345189
1	Study of XL820 Given Orally Daily to Subjects With Solid Tumors	Completed	Closed	XL820	NCT00350831
1	A Phase I/II Study of BGT226 in Adult Patients With Advanced Solid Malignancies Including Patients With Advanced Breast Cancer	Completed	Closed	BGT226	NCT00600275
1	Study of XL820 in Adults With Solid Tumors	Completed	Closed	XL820	NCT00129571
1	Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors	Completed	Closed	MSC1936369B + SAR245409	NCT01390818